Related references
Note: Only part of the references are listed.Clinical Implications of Body Mass Index in Metastatic Breast Cancer Patients Treated With Abemaciclib and Endocrine Therapy
Maria Alice Franzoi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
Pharmacokinetics of Trastuzumab After Subcutaneous and Intravenous Administration in Obese Patients
Jonathan Gonzalez Garcia et al.
ANNALS OF PHARMACOTHERAPY (2020)
Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008-2016
Elise Deluche et al.
EUROPEAN JOURNAL OF CANCER (2020)
The ongoing French metastatic breast cancer (MBC) cohort: the example-based methodology of the Epidemiological Strategy and Medical Economics (ESME)
David Perol et al.
BMJ OPEN (2019)
Metabolically activated adipose tissue macrophages link obesity to triple-negative breast cancer
Payal Tiwari et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
UNICANCER: French prospective cohort study of treatment-related chronic toxicity in women with localised breast cancer (CANTO)
Ines Vaz-Luis et al.
ESMO OPEN (2019)
Impact of body composition on outcome in patients with early breast cancer
Elise Deluche et al.
SUPPORTIVE CARE IN CANCER (2018)
Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer
Samuel Martel et al.
BREAST (2018)
Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab
Laura Pizzuti et al.
CANCER BIOLOGY & THERAPY (2018)
The Importance of Body Composition in Explaining the Overweight Paradox in Cancer
Bette J. Caan et al.
CANCER RESEARCH (2018)
Clinical implication of changes in body composition and weight in patients with early-stage and metastatic breast cancer
Ilaria Trestini et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
BMI and outcomes in melanoma: more evidence for the obesity paradox
Andrew J. Hayes et al.
LANCET ONCOLOGY (2018)
Association of Muscle and Adiposity Measured by Computed Tomography With Survival in Patients With Non metastatic Breast Cancer
Bette J. Caan et al.
JAMA ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Changes in body composition and muscle attenuation during taxane-based chemotherapy in patients with metastatic breast cancer
Hanah N. Rier et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Skeletal Muscle Measures as Predictors of Toxicity, Hospitalization, and Survival in Patients with Metastatic Breast Cancer Receiving Taxane-Based Chemotherapy
Shlomit Strulov Shachar et al.
CLINICAL CANCER RESEARCH (2017)
Explaining the Obesity Paradox: The Association between Body Composition and Colorectal Cancer Survival (C-SCANS Study)
Bette J. Caan et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Body Mass Index at Diagnosis and Breast Cancer Survival Prognosis in Clinical Trial Populations from NRG Oncology/NSABP B-30, B-31, B-34, and B-38
Reena S. Cecchini et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2016)
Impact of body mass index (BMI) on the prognosis of high-risk early breast cancer (EBC) patients treated with adjuvant chemotherapy
Alessandra Gennari et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review
Shlomit Strulov Shachar et al.
EUROPEAN JOURNAL OF CANCER (2016)
Proportion of premenopausal and postmenopausal breast cancers attributable to known risk factors: Estimates from the E3N-EPIC cohort
Laureen Dartois et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Obesity and Breast Cancer Prognosis: Evidence, Challenges, and Opportunities
Sao Jiralerspong et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Body Fatness and Cancer - Viewpoint of the IARC Working Group
Beatrice Lauby-Secretan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Overweight and obesity predict better overall survival rates in cancer patients with distant metastases
Ngan Ming Tsang et al.
CANCER MEDICINE (2016)
Leptin produced by obese adipose stromal/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers
Amy L. Strong et al.
BREAST CANCER RESEARCH (2015)
Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies
D. S. M. Chan et al.
ANNALS OF ONCOLOGY (2014)
Body Mass Index and Prognosis of Metastatic Breast Cancer Patients Receiving First-Line Chemotherapy
Alessandra Gennari et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
Body mass index and survival in patients with renal cell carcinoma: A clinical-based cohort and meta-analysis
Yuni Choi et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Factors associated with mortality after breast cancer metastasis
Su Yon Jung et al.
CANCER CAUSES & CONTROL (2012)
Adipose tissue and breast epithelial cells: A dangerous dynamic duo in breast cancer
Yuan-Yuan Wang et al.
CANCER LETTERS (2012)
Effect of Obesity on Prognosis After Early-Stage Breast Cancer
Marianne Ewertz et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Obesity Is an Independent Predictor of Poor Survival in Metastatic Breast Cancer: Retrospective Analysis of a Patient Cohort Whose Treatment Included High-Dose Chemotherapy and Autologous Stem Cell Support
A. von Drygalski et al.
INTERNATIONAL JOURNAL OF BREAST CANCER (2011)
Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment
Carla M. M. Prado et al.
CLINICAL CANCER RESEARCH (2009)
Body size and breast cancer risk:: Findings from the european prospective investigation into cancer and nutrition (EPIC)
PH Lahmann et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Body mass index as a prognostic feature in operable breast cancer:: the International Breast Cancer Study Group experience
G Berclaz et al.
ANNALS OF ONCOLOGY (2004)
Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: A nationwide study of community practices
GH Lyman et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Share Paper
